Seeing Is Believing
Currently out of the existing stock ratings of Daniel Markowitz, 37 are a BUY (84.09%), 7 are a HOLD (15.91%).
Analyst Daniel Markowitz, currently employed at EVERCORE, carries an average stock price target met ratio of 49.76% that have a potential upside of 15.26% achieved within 79 days.
Daniel Markowitz’s has documented 88 price targets and ratings displayed on 9 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on NTRA, Natera at 07-Aug-2026.
Analyst best performing recommendations are on TECH (BIO-TECHNE CORP).
The best stock recommendation documented was for TECH (BIO-TECHNE CORP) at 5/7/2026. The price target of $50 was fulfilled within 1 day with a profit of $0.91 (1.79%) receiving and performance score of 17.87.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Sep-2025
$135
$40.08 (42.23%)
$130
Buy Since 23-Jan-2025
$120
$25.08 (26.42%)
$115
Buy Since 26-Feb-2024
$130
$35.08 (36.96%)
$120
Buy Since 16-Apr-2019
$145
$50.08 (52.76%)
$140
Buy Since 11-Jan-2021
$130
$35.08 (36.96%)
$120
Which stock is Daniel Markowitz is most bullish on?
Which stock is Daniel Markowitz is most reserved on?
What Year was the first public recommendation made by Daniel Markowitz?